(Q83961413)

English

Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy

scientific article published on 09 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Vedder AC

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Cox-Brinkman J

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hollak CE

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Linthorst GE

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Groener JE

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Helmond MT

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Scheij S

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

9 June 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

89

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

239-244

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Enzymatic Defect in Fabry's Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Fabry's Disease: Alpha-Galactosidase Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Fabry disease: overall effects of agalsidase alfa treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Elevated plasma chitotriosidase activity in various lysosomal storage disorders.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

The human chitotriosidase gene. Nature of inherited enzyme deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Plasma and metabolic abnormalities in Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Ultrastructural and biochemical liver analyses in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Monitoring enzyme replacement therapy in Fabry disease--role of urine globotriaosylceramide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

Clinically relevant therapeutic endpoints in type I Gaucher disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

X-chromosome inactivation and human genetic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.04.013

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMGME.2006.04.013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765076%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83961413&oldid=1746097369"